Skip to main content

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest Expense (QFR105385USNO)

Observation:

Q4 2022: 6,050 (+ more)  Updated: Mar 20, 2023
Q4 2022:  6,050  
Q3 2022:  5,850  
Q2 2022:  5,299  
Q1 2022:  5,372  
Q4 2021:  5,512  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES
Title Release Dates

2017-09-06 2023-03-20
 
Source    

2017-09-06 2023-03-20
 
Release    

2017-09-06 2023-03-20
 
Units    

2017-09-06 2023-03-20
 
Frequency    

2017-09-06 2023-03-20
 
Seasonal Adjustment    

2017-09-06 2023-03-20
 
Notes    

2017-09-06 2023-03-20

Subscribe to the FRED newsletter

Follow us

Back to Top
Top